AQR Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.77M | Buy |
53,944
+16,443
| +44% | +$1.15M | ﹤0.01% | 1442 |
|
|
2025
Q1 | $2.76M | Buy |
37,501
+11,690
| +45% | +$859K | ﹤0.01% | 1435 |
|
|
2024
Q4 | $1.69M | Buy |
25,811
+6,947
| +37% | +$455K | ﹤0.01% | 1623 |
|
|
2024
Q3 | $1.47M | Buy |
18,864
+5,179
| +38% | +$404K | ﹤0.01% | 1649 |
|
|
2024
Q2 | $1.07M | Buy |
13,685
+7,241
| +112% | +$565K | ﹤0.01% | 1724 |
|
|
2024
Q1 | $437K | Buy |
6,444
+1,341
| +26% | +$90.9K | ﹤0.01% | 2003 |
|
|
2023
Q4 | $344K | Buy |
5,103
+363
| +8% | +$24.4K | ﹤0.01% | 2019 |
|
|
2023
Q3 | $321K | Buy |
+4,740
| New | +$321K | ﹤0.01% | 1991 |
|
|
2014
Q3 | – | Sell |
-2,372,836
| Closed | -$88.2M | – | 2513 |
|
|
2014
Q2 | $88.2M | Buy |
+2,372,836
| New | +$88.2M | 0.24% | 101 |
|